Toshihiro Morita Selected Research

Toshihiro Morita Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 09/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2013 - 12/2006
4	Neoplasms (Cancer) 10/2023 - 01/2006
4	Pulmonary Arterial Hypertension 09/2015 - 10/2006
4	Atherosclerosis 02/2014 - 03/2003
4	Thrombosis (Thrombus) 02/2013 - 08/2009
4	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2009 - 12/2006
3	Necrosis 09/2021 - 02/2014
3	Ischemia 01/2015 - 12/2002
2	Ulcerative Colitis 03/2024 - 01/2021
2	Pancreatitis 09/2021 - 11/2018
2	Immunoglobulin G4-Related Disease 01/2018 - 01/2016
2	Wounds and Injuries (Trauma) 01/2018 - 01/2016
2	Inflammation (Inflammations) 02/2014 - 07/2013
2	Non-ST Elevated Myocardial Infarction 07/2011 - 06/2011
2	Unstable Angina 07/2011 - 06/2011
1	Colitis 03/2024
1	Abscess 10/2023
1	Margins of Excision 07/2022
1	Hemorrhage 05/2021
1	Diverticular Diseases 05/2021
1	Autoimmune Pancreatitis 01/2018
1	Diabetic Cardiomyopathies 11/2014
1	Hyperplasia 02/2014
1	Vascular Diseases (Vascular Disease) 02/2014
1	Neointima 02/2014
1	Acute Coronary Syndrome 06/2011
1	Coronary Occlusion 06/2011
1	ST Elevation Myocardial Infarction 06/2011
1	Chronic Renal Insufficiency 11/2010
1	Hypoxia (Hypoxemia) 07/2010
1	Syncope (Fainting) 11/2008
1	Hypotension (Low Blood Pressure) 11/2008
1	Orthostatic Intolerance 06/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2016
3	Sirolimus (Rapamycin)FDA Link 02/2009 - 04/2007
2	IntegrinsIBA 03/2024 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2021
2	AutoantibodiesIBA 03/2024 - 01/2021
2	AutoantigensIBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2021 - 01/2018
2	erucylphosphocholineIBA 09/2015 - 01/2015
2	MonocrotalineIBA 01/2012 - 01/2007
2	FibrinIBA 07/2011 - 06/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010 - 09/2005
2	Retinaldehyde (Retinal)IBA 11/2007 - 12/2006
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2006 - 03/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2006 - 03/2003
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2004 - 03/2003
1	SteroidsIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	ThrombomodulinIBA 09/2021
1	ImmunosorbentsIBA 01/2021
1	EnzymesIBA 01/2021
1	arginyl-glycyl-aspartic acidIBA 01/2021
1	VimentinIBA 10/2020
1	ChemokinesIBA 11/2018
1	Chemokine CXCL16IBA 11/2018
1	CeruletideIBA 11/2018
1	CytokinesIBA 11/2018
1	AntigensIBA 01/2018
1	laminin 10IBA 01/2018
1	Laminin (Merosin)IBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 11/2014
1	Angiotensin-Converting Enzyme 2IBA 02/2014
1	Angiotensin IIIBA 02/2014
1	ApolipoproteinsIBA 02/2014
1	Monocyte Chemoattractant ProteinsIBA 02/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2014
1	Matrix Metalloproteinases (MMPs)IBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	Amiodarone (Amiodarona)FDA LinkGeneric 02/2013
1	Potassium Channels (Potassium Channel)IBA 02/2013
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	Nicorandil (SG 75)IBA 01/2012
1	Coloring Agents (Dyes)IBA 06/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2011
1	oxidized low density lipoproteinIBA 01/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2011
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2011
1	Cystatin CIBA 11/2010
1	CreatinineIBA 11/2010
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 07/2010
1	Vardenafil Dihydrochloride (Levitra)FDA Link 07/2010
1	Phosphodiesterase 5 InhibitorsIBA 07/2010
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 07/2010

Therapy/Procedure

4	Stents 08/2009 - 04/2007
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2009 - 12/2006
2	Lower Body Negative Pressure 11/2008 - 06/2007
2	Therapeutics 10/2006 - 11/2004
1	Gastrectomy 10/2023
1	Operative Surgical Procedures 07/2022
1	Ligation 05/2021
1	Subcutaneous Injections 01/2016
1	Drug-Eluting Stents 08/2009
1	Bed Rest (Bedrest) 11/2008
1	Intravenous Injections 01/2007